Using cholesterol-modified oligonucleotides, the research team aims to improve the delivery of antisense nucleotide-based therapies for treating neurodegenerative diseases and brain cancers.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Thermo Fisher Opens Advanced Therapies Collaboration Center in California

By Patrick Lavery

April 18th 2025

The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.

Cellino Partners with Karis Bio for Autologous iPSC Therapy to Treat Cardiovascular Disease

By Feliza Mirasol

April 18th 2025

This collaboration aims to advance a first-in-human clinical study by using autologous iPSC technology.

Teva and Samsung Bioepis Launch Biosimilar Eculizumab in US Market

By Feliza Mirasol

April 17th 2025

Eculizumab-aagh (EPYSQLI) is now available in the US to treat patients living with difficult-to-treat rare diseases such as paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and generalized myasthenia gravis.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novartis Expands Manufacturing and R&D Capacity in the US

By Susan Haigney

April 11th 2025

Novartis will invest $23 billion during the next five years to expand manufacturing and R&D in the US, which will include seven new facilities and a new research hub.

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Visit Now

Research into Cold Cancers Heating Up; Image: catalin - stock.adobe.com

...

54 55 56 57 58

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777